Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
Therapeutic Advances in Medical Oncology|February 22, 2021
Update on systemic treatment in early triple negative breast cancerMartín Núñez Abad, Silvia Calabuig-Fariñas, Miriam Lobo de Mena, et al.European Journal of Medicinal Chemistry|January 15, 2008
Activity of a hydroxybibenzyl bryophyte constituent against Leishmania spp. and Trypanosoma cruzi: in silico, in vitro and in vivo activity studiesVirginia Roldos, Hector Nakayama, Miriam Rolón, et al.Antimicrobial Agents and Chemotherapy|December 17, 2014
Identification of a new amide-containing thiazole as a drug candidate for treatment of Chagas' diseaseGuzmán Álvarez, Javier Varela, Eugenia Cruces, et al.Journal of Ethnopharmacology|December 8, 2010
Zanthoxylum chiloperone leaves extract: first sustainable Chagas disease treatmentMaria Elena Ferreira, Gerardo Cebrián-Torrejón, Alba Segovia Corrales, et al.European Journal of Medicinal Chemistry|August 19, 2008
In vitro and in vivo antitrypanosomatid activity of 5-nitroindazolesLucia Boiani, Alejandra Gerpe, Vicente J Arán, et al.Journal of Medicinal Chemistry|May 26, 2006
2H-benzimidazole 1,3-dioxide derivatives: a new family of water-soluble anti-trypanosomatid agentsMariana Boiani, Lucía Boiani, Ana Denicola, et al.Cancers|July 9, 2022
Analysis of Exosomal Cargo Provides Accurate Clinical, Histologic and Mutational Information in Non-Small Cell Lung CancerElena Duréndez-Sáez, Silvia Calabuig-Fariñas, Susana Torres-Martínez, et al.Healthcare (Basel, Switzerland)|November 27, 2021
Do Brief Mindfulness Interventions (BMI) and Health Enhancement Programs (HEP) Improve Sleep in Patients in Hemodialysis with Depression and Anxiety?Paola Lavin, Rim Nazar, Marouane Nassim, et al.Healthcare (Basel, Switzerland)|July 2, 2021
Brief Mindfulness Intervention vs. Health Enhancement Program for Patients Undergoing Dialysis: A Randomized Controlled TrialMarouane Nassim, Haley Park, Elena Dikaios, et al.Pharmaceuticals (Basel, Switzerland)|January 21, 2023
Preclinical Studies and Drug Combination of Low-Cost Molecules for Chagas DiseaseElena Aguilera, Carina Sánchez, María Eugenia Cruces, et al.Pageof 6